IAMOG
CVS icon

Investors Asset Management of Georgia’s CVS Health CVS Stock Holding History

Investors Asset Management of Georgia’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
11,734
+606
+5% +$54.1K 0.42% 65
2026
Q1 		$799K Buy
11,128
+978
+10% +$75.3K 0.33% 78
2025
Q4 		$806K Buy
10,150
+303
+3% +$23.9K 0.33% 76
2025
Q3 		$742K Buy
9,847
+529
+6% +$36.3K 0.32% 83
2025
Q2 		$643K Sell
9,318
-397
-4% -$26K 0.3% 84
2025
Q1 		$658K Sell
9,715
-190
-2% -$11.4K 0.33% 77
2024
Q4 		$445K Sell
9,905
-816
-8% -$45.8K 0.22% 99
2024
Q3 		$674K Buy
10,721
+609
+6% +$35.5K 0.32% 80
2024
Q2 		$597K Sell
10,112
-516
-5% -$32.3K 0.29% 81
2024
Q1 		$848K Sell
10,628
-496
-4% -$37.9K 0.4% 67
2023
Q4 		$878K Buy
11,124
+53
+0.5% +$3.77K 0.45% 64
2023
Q3 		$763K Buy
11,071
+2,052
+23% +$145K 0.42% 65
2023
Q2 		$623K Buy
9,019
+402
+5% +$28.6K 0.32% 80
2023
Q1 		$640K Buy
8,617
+2
+0% +$168 0.34% 79
2022
Q4 		$803K Buy
8,615
+1
+0% +$96 0.42% 66
2022
Q3 		$822K Sell
8,614
-199
-2% -$19.7K 0.42% 63
2022
Q2 		$817K Sell
8,813
-313
-3% -$30.5K 0.42% 66
2022
Q1 		$924K Buy
9,126
+17
+0.2% +$1.79K 0.47% 62
2021
Q4 		$940K Buy
9,109
+326
+4% +$30.1K 0.45% 61
2021
Q3 		$745K Buy
8,783
+1,121
+15% +$93.9K 0.39% 69
2021
Q2 		$639K Buy
7,662
+498
+7% +$40.8K 0.34% 77
2021
Q1 		$539K Buy
7,164
+2,650
+59% +$193K 0.31% 82
2020
Q4 		$308K Sell
4,514
-2,465
-35% -$160K 0.21% 103
2020
Q3 		$408K Buy
6,979
+475
+7% +$29.6K 0.27% 83
2020
Q2 		$423K Buy
6,504
+240
+4% +$15.1K 0.29% 74
2020
Q1 		$372K Buy
6,264
+277
+5% +$18.5K 0.3% 72
2019
Q4 		$445K Buy
5,987
+50
+0.8% +$3.51K 0.27% 86
2019
Q3 		$374K Buy
5,937
+875
+17% +$51.9K 0.24% 97
2019
Q2 		$276K Buy
+5,062
New +$273K 0.19% 119

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Investors Asset Management of Georgia's CVS Position: Q2 2026 in Review

Investors Asset Management of Georgia increased its CVS Health (CVS) stake by 5.4% in Q2 2026, buying an estimated $54.1K and bringing the position to 11,734 shares worth $1.21M. The position accounts for 0.42% of the portfolio, ranked #65.

Investors Asset Management of Georgia first reported a position in CVS in Q2 2019 and has held it in 29 quarters since. 1,595 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Investors Asset Management of Georgia held 11,734 shares of CVS Health worth $1.21M as of Q2 2026.
  • Investors Asset Management of Georgia bought 606 CVS Health shares in Q2 2026, an estimated $54.1K.
  • CVS Health made up 0.42% of Investors Asset Management of Georgia's portfolio in Q2 2026, its #65 holding.
  • Investors Asset Management of Georgia first reported a position in CVS Health in Q2 2019 and has held it in 29 quarters since.
  • 1,595 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Investors Asset Management of Georgia's 13F filing for Q2 2026, filed 22 Jul 2026.